FDA oncologic gene and cellular therapies
Executive Summary
FDA Division of Oncologic Drug Products Medical Officer Steven Hirschfeld, MD/PhD, will become Oncology Group Leader in the Office of Cellular, Gene & Tissue Therapies in the Center for Biologics Evaluation & Research. Hirschfeld assumes the position starting Nov. 3...